Birth Control and Mood: Can Hormonal Contraception Affect Depression and Anxiety?

Last reviewed: 07/28/2026

Reviewed by: Dr. Kiesa Kelly

If you have searched this question, you have probably already found two confident and completely opposite answers. One set of headlines says birth control causes depression. Another says that has been debunked. Both are citing real research, and neither is telling you the whole thing.

Here is what is actually true: this is one of the genuinely unsettled questions in women's mental health. Very large population studies keep finding a modest association between hormonal contraception and later depression. Randomized trials — the design built specifically to test cause and effect — mostly do not. That is not a case of good science versus bad science. It is two research designs with different blind spots, answering slightly different questions, and the disagreement between them is itself informative.

This article walks through what each body of evidence found, why they diverge, and — most usefully — how you and a clinician can tell whether what you are experiencing is connected to your method, connected to something else, or both.

One thing to say plainly at the outset: we do not prescribe contraception. Nothing here is a recommendation to start, stop, or switch anything. That decision belongs with your prescribing clinician. What we can do is help you figure out what is actually happening with your mood, and treat it.

In this article, you'll learn:

• What the large population studies found, including the numbers and who they applied to

• What randomized trials found, and why the two literatures disagree

• Why "mood" and "depression" are not the same outcome — and why that explains a lot

• Who appears most likely to notice a mood change on hormonal contraception

• How to distinguish a method-linked mood shift from an underlying mood disorder

• What to ask your prescriber, and where therapy fits

Three things people get wrong about this question

"There's a definitive answer and I just haven't found it yet"

There isn't one, and any source giving you an unqualified yes or no is overstating its case. A 2025 review of hormonal contraception and affective disorders describes a literature that remains genuinely inconsistent across study designs, populations, and outcome measures [1]. That is frustrating if you want a clean answer, but it is the accurate state of the field — and knowing that the evidence is mixed is itself useful, because it means your individual experience carries more weight in the decision than a population average does.

"A large study proved it, so it applies to me"

The headline finding most people have encountered comes from a Danish study of more than a million women [2]. It is excellent research. But a relative risk describes how much more often something happens across a whole population — not whether it will happen to you, and not that the method caused it in any individual case. Observational studies also cannot fully exclude the possibility that people who start, continue, or stop a method differ in other ways that affect mood.

"If it were real, my doctor would have warned me"

Mood change is a recognized and commonly reported reason people discontinue hormonal contraception, and it comes up frequently in counseling. What has been harder is quantifying it. When a symptom is common, subjective, and has many possible causes, it is genuinely difficult to attribute — which is different from it not being real. If you noticed something, that observation is data, and it is worth bringing to the person who prescribed the method.

🧪 Key takeaway: The disagreement in this literature is real, not a sign that someone is wrong. Large observational studies and randomized trials are answering different questions with different blind spots.

What the large population studies found

The most-cited study is a Danish national cohort of 1,061,997 women aged 15 to 34, followed for an average of 6.4 years [2]. Everyone with a prior depression diagnosis or antidepressant prescription was excluded at the outset, so the study was tracking new cases. Compared with non-users:

• Combined oral contraceptives carried a relative risk of first antidepressant use of 1.23 (95% CI 1.22–1.25)

• Progestin-only pills, 1.34 (1.27–1.40)

• The levonorgestrel intrauterine system, 1.4 (1.31–1.42)

• The vaginal ring, 1.6 (1.55–1.69); the patch, 2.0 (1.76–2.18)

Risk rose over the first months of use and peaked at around six months [2]. The pattern by age was the most striking part: among adolescents aged 15 to 19, combined oral contraceptives were associated with a 1.8-fold higher rate of first antidepressant use (1.75–1.84), and non-oral methods with roughly a three-fold increase [2]. That age gradient has held up elsewhere. A Swedish pharmacoepidemiological study of 800,000 women found increased psychotropic drug use associated with hormonal contraception in adolescent girls but not in adults [3], and a separate cohort study found that oral contraceptive use during adolescence predicted greater vulnerability to depression later in adulthood [4].

Those relative risks are real but modest for adults, and it is worth translating what 1.23 means: for most adult users, a roughly one-in-five proportional increase on an event that is uncommon to begin with. It is a population signal, not a prediction about an individual.

The observational picture is not unanimous, either. A Swedish register-based cohort of around 740,000 women reported no association between combined oral contraceptives and depression [5]. A large U.S. study found hormonal contraceptive use associated with reduced depressive symptoms [6]. And a systematic review focused specifically on progestin-only methods — 26 studies including 5 randomized trials — concluded that progestin-based contraception does not increase depression risk, with several studies finding slightly lower depression scores among users [7].

What the randomized trials found

If hormonal contraception caused depression, randomized trials should show it. They largely do not.

A systematic review and network meta-analysis pooled 12 randomized trials covering 5,833 participants and 10 different interventions, comparing hormonal contraception against placebo or other methods [8]. The result: no worsening of depressive symptoms attributable to hormonal contraceptive use, with a median standardized mean difference of −0.04 — statistically and clinically indistinguishable from zero [8]. The authors concluded that hormonal contraceptive use does not lead to an increase in depressive symptoms in adult women, while explicitly noting that future studies should include first-time users to confirm the finding in younger women [8].

That last caveat is the crux. Randomized trials in this area typically run about three cycles, usually enroll adults rather than adolescents, and frequently exclude people trying a method for the first time. The observational signal is strongest in adolescents, in first-time starters, and at around six months of use. The trials are, to a large extent, not looking where the signal is.

Meanwhile the observational evidence has continued to accumulate. A 2026 meta-analysis pooling 14 studies and nearly 2.5 million participants reported that oral contraceptive use was associated with a 31% higher relative risk of receiving a depression diagnosis and a 25% higher relative risk of starting an antidepressant, along with a small increase in depressive symptom scores [9].

So both literatures have grown, and both have held their shape.

⚖️ Key takeaway: Randomized trials say no measurable effect on depressive symptoms in adults over three cycles. Registry studies say a modest association, concentrated in adolescents and early months of use. Both can be true at once.

Why they might genuinely disagree

Three explanations are doing most of the work, and they are not mutually exclusive.

Confounding that observational designs cannot fully remove. People who start, continue, or stop hormonal contraception differ from those who do not in ways that also relate to mood — relationship changes, life stage, underlying conditions like PCOS or endometriosis, and healthcare-seeking behavior. A 2025 study examined this directly and found evidence of genetic confounding in the association between age at first hormonal contraception and depression, meaning shared underlying liability explains part of what looks like a causal link [10].

Reverse causation and detection effects. Someone already low in mood is more likely to notice, attribute, and report side effects — and more likely to discontinue. Research has found that baseline depressed mood and psychological stress predict perceived oral contraceptive side effects and discontinuation [11]. Additionally, starting a contraceptive means seeing a clinician, which itself raises the chance that an existing depression is recognized and recorded.

Real effects in a subgroup, diluted in the average. If a minority of people are genuinely sensitive to a particular formulation, a trial averaging across everyone will show close to zero while the sensitive subgroup's experience is completely real. This is the explanation most consistent with what clinicians actually see, and with the age findings.

"Mood" and "depression" are not the same outcome

This distinction resolves more confusion than anything else in this article.

A double-blind, randomized, placebo-controlled trial gave 340 healthy women either a common combined oral contraceptive or placebo for three months [12]. The result is genuinely interesting: the contraceptive group showed a statistically significant decrease in general well-being compared with placebo (−4.12, 95% CI −7.18 to −1.06), with specific declines in positive well-being, self-control, and vitality — but no statistically significant effect on depressive symptoms [12].

Read that carefully, because it is the shape of the whole debate in a single study. Something measurable happened. It was not depression.

That matters for you as a reader, because "I don't feel like myself," "I feel flattened," "I have less energy," and "I don't care about things I used to care about" are not the same complaint as clinical depression — and a study designed to detect depression will report a null result while the thing you are experiencing goes unmeasured. It also matters clinically: a change in vitality or emotional range is a legitimate reason to talk to your prescriber about options. You do not have to meet criteria for a depressive disorder for your experience to count.

🔬 Key takeaway: One randomized trial found hormonal contraception measurably reduced general well-being, vitality, and self-control — while leaving depression scores unchanged. "Not depression" does not mean "nothing."

Who seems most likely to notice a change

The research points fairly consistently at a few groups, though none of this is destiny:

• Adolescents and first-time users. The most consistent finding across the observational literature [2][3][4].

• People with a current or prior mental health condition. A study of combined oral contraceptive users found that ongoing or previous mental disorders predisposed people to reporting adverse mood during use [13].

• People with a history of hormone-sensitive mood change. If your mood has historically tracked your cycle, the postpartum period, or another reproductive transition, that pattern is clinically meaningful. One large study found that depression associated with hormonal contraceptive use functioned as a risk indicator for later postpartum depression — suggesting a shared underlying sensitivity to hormonal shifts rather than a quirk of one method [14].

That last point is worth holding onto, because it reframes the question productively. If you are someone whose mood responds to hormonal change, that is a fact about you that is useful across your whole reproductive life — not just for this decision. The broader relationship between hormones and mental health is the wider frame here, and patterns like PMDD and perimenopausal mood change belong to the same family of questions.

Telling a method-linked shift from an underlying mood disorder

This is the practical part, and it is where careful observation beats any population statistic.

A decision heuristic

If the change began within roughly one to three months of starting or switching a method, represents a clear departure from your baseline, and is not better explained by sleep loss, a major stressor, or a pre-existing condition — a method-linked effect is worth investigating with your prescriber.

If the low mood predates the method, or began much later without any change in method, or tracks a cycle pattern you had before starting — the more likely explanation is a mood condition in its own right, which deserves assessment and treatment regardless of what you decide about contraception.

If both look true, that is common and not a contradiction. Hormonal sensitivity and an independent mood condition frequently coexist, and untangling them is exactly the kind of question a structured assessment is for.

What to actually track

Recall is unreliable for exactly this kind of question, and prescribers can act on dated notes in a way they cannot act on impressions. Useful things to log daily for six to eight weeks: mood rated simply, sleep hours and quality, energy, irritability, anxiety, and where you are in your cycle if you have one. The approach used for cycle tracking for mental-health patterns works well here; the only adjustment is marking the date you started or changed a method as a reference line.

Two validated screeners can add structure to that picture: the PHQ-9 for depressive symptoms and the GAD-7 for anxiety. Repeating them monthly gives you a trend line rather than a single impression. A screener is a starting point, not a diagnosis — but a trend line is genuinely persuasive information to bring to an appointment, and our screening overview explains what each one does and doesn't tell you.

📅 Key takeaway: Timing and trajectory are the most useful evidence you can gather. A dated log spanning the method change is worth more to a prescriber than any statistic in this article.

Questions worth asking your prescriber

Because this decision is theirs and yours together, arriving with specific questions changes the conversation:

• "I've noticed this pattern since starting this method — is a different formulation or delivery route worth considering?" Different progestins and different routes carry different exposures; this is a real conversation with real options.

• "If we change something, how long should we expect to wait before judging whether it helped?" Prevents a premature switch, and sets a shared timeline.

• "What are my non-hormonal options, and what would I be trading off?" Every method has a profile; you are entitled to the comparison.

• "If I stop or switch, what do I need to know about pregnancy risk in the meantime?" The single most important practical question, and the reason not to stop a method on your own.

• "Would it be reasonable to treat the mood symptoms directly while we sort out the contraceptive question?" These are not sequential problems. They can be addressed in parallel.

ACOG's guidance on contraceptive counseling frames the roles clearly: the clinician is the expert in the clinical information, and you are the expert in your own experience, values, and priorities — with the decision ultimately yours [15]. If you have felt dismissed on this topic before, that framing is worth knowing about.

Where therapy fits — and where it doesn't

We do not prescribe or manage contraception, and we would not advise you on which method to use. What we do is assess and treat the mood symptoms themselves.

That is genuinely useful in this situation for two reasons. First, whatever the cause, depression and anxiety respond to evidence-based treatment, and there is no reason to wait out a contraceptive question before addressing symptoms that are affecting your life now. Cognitive behavioral therapy for depression does not require a settled answer about etiology to work. Second, a structured psychological assessment can help clarify what is actually going on — whether this is a discrete change from a clear baseline, a long-standing pattern that predates the method, a cycle-linked pattern like PMDD, or a hormone-sensitivity picture that also shows up at other reproductive transitions such as the perimenopausal years. That clarity is exactly what makes the conversation with your prescriber more productive.

In practice we work alongside your OB-GYN, midwife, or primary care provider — providing the mental-health picture, while they hold the prescribing decisions. If you want therapy for the mood symptoms while you work the contraceptive question out with your prescriber, that is a completely reasonable order of operations.

🤝 Key takeaway: You do not have to resolve the contraception question before treating the mood symptoms. They can be worked on at the same time, by different people, in parallel.

Where this leaves you

The evidence does not support telling anyone that hormonal contraception causes depression. It also does not support telling anyone that a mood change they noticed after starting a method is imaginary. Both of those are overreaches, and both are common online.

What the research supports is narrower and more useful: for most adult users, randomized evidence shows no measurable increase in depressive symptoms; a modest association appears consistently in large population data, concentrated in adolescents and in the early months of use; well-being and vitality can shift measurably without depression scores moving at all; and some people are genuinely more hormone-sensitive than others.

If you are one of them, that is worth knowing — and it is worth writing down, because the pattern you can document is the thing that turns an uncertain literature into a decision that actually fits you.

Anxiety running the show?

Evidence-based therapy can turn the volume down on anxiety — a clinician can help you find the approach that fits your life rather than a one-size-fits-all plan.

Schedule an anxiety consultation →

Frequently Asked Questions

can birth control cause depression?

The honest answer is that the evidence is genuinely split. Large national registry studies have repeatedly found that people starting hormonal contraception are somewhat more likely to be diagnosed with depression or start an antidepressant, with the strongest signal in adolescents. Randomized trials comparing hormonal contraception with placebo have generally not found an increase in depressive symptoms in adults. Both bodies of evidence are real, and they measure different things.

How would I know if my birth control is affecting my mood?

Timing and pattern are the most useful signals. A contraception-linked mood change usually starts within the first few months of beginning or switching a method, does not track your old premenstrual pattern, and is not better explained by sleep loss, a life stressor, or an existing condition. Dated notes on mood, sleep, and energy — kept from before the change if possible — give a prescriber far more to work with than recall alone.

Does the hormonal IUD affect mood the same way as the pill?

Not identically, and the evidence differs by method. In the large Danish cohort study, the levonorgestrel intrauterine system carried a somewhat higher relative risk of first antidepressant use than combined pills, while a systematic review focused specifically on progestin-only methods found no consistent increase in depression risk. Systemic hormone exposure is lower with an IUD than with most pills, but individual responses vary and the research has not settled this.

Should I stop my birth control if I think it's affecting my mood?

That decision belongs with the clinician who prescribed it, not with an article — and not with us, since we do not prescribe. Stopping a method abruptly carries a real risk of unintended pregnancy, and some methods need a planned transition. Bring the pattern you have noticed to your prescriber and ask about options; there are usually several, including changing formulation, changing method, or treating the mood symptoms directly.

Why do studies disagree about birth control and depression?

They are answering slightly different questions. Registry studies follow millions of people for years but cannot fully rule out that those who choose or keep using a method differ from those who do not. Randomized trials remove that problem but typically run only about three cycles, mostly enroll adults, and often exclude first-time users — which is precisely the group where the observational signal is strongest. Neither design is wrong; each has a blind spot the other covers.

About the Author

Dr. Kiesa Kelly is a licensed clinical psychologist (PhD) and the founder of ScienceWorks Behavioral Healthcare, with more than 20 years of experience in psychological assessment and evidence-based treatment. Her clinical training includes work at the University of Chicago, Vanderbilt University, and the University of Wisconsin, and her practice centers on structured evaluation and therapy for adults and adolescents — including depression, anxiety, and the differential questions that arise around hormonal and reproductive transitions.

Dr. Kelly's approach emphasizes accurate assessment as the foundation of good care: understanding what is actually happening for a person before deciding what will help. She is a PhD clinical psychologist, not a medical doctor, and does not prescribe or manage contraception. For questions with a medical or prescribing dimension, she works alongside a person's OB-GYN, midwife, or primary care provider rather than in place of them.

References

1. Mengelkoch S, Afshar K, Slavich GM. Hormonal contraceptive use and affective disorders: an updated review. Open Access J Contracept. 2025;16:1-29. https://doi.org/10.2147/OAJC.S431365

2. Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73(11):1154-1162. https://doi.org/10.1001/jamapsychiatry.2016.2387

3. Zettermark S, Perez Vicente R, Merlo J. Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: a pharmacoepidemiological study on 800 000 Swedish women. PLoS One. 2018;13:e0194773. https://doi.org/10.1371/journal.pone.0194773

4. Anderl C, Li G, Chen FS. Oral contraceptive use in adolescence predicts lasting vulnerability to depression in adulthood. J Child Psychol Psychiatry. 2020;61:148-156. https://doi.org/10.1111/jcpp.13115

5. Lundin C, Wikman A, Lampa E, et al. There is no association between combined oral hormonal contraceptives and depression: a Swedish register-based cohort study. BJOG. 2022;129:917-925. https://doi.org/10.1111/1471-0528.17028

6. Keyes KM, Cheslack-Postava K, Westhoff C, et al. Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States. Am J Epidemiol. 2013;178:1378-1388. https://doi.org/10.1093/aje/kwt188

7. Worly BL, Gur TL, Schaffir J. The relationship between progestin hormonal contraception and depression: a systematic review. Contraception. 2018;97(6):478-489. https://pubmed.ncbi.nlm.nih.gov/29496297/

8. de Wit AE, de Vries YA, de Boer MK, Scheper C, Fokkema AA, Schoevers RA, et al. Hormonal contraceptive use and depressive symptoms: systematic review and network meta-analysis of randomised trials. BJPsych Open. 2021;7(4):e110. https://doi.org/10.1192/bjo.2021.64

9. Davies Kellock M, et al. Association of oral contraceptives with depression symptoms, diagnosis, and treatment in healthy women: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2026. https://www.ejog.org/article/S0301-2115(26)00211-3/fulltext

10. Mundy J, Hall ASM, Agerbo E, et al. Genetic confounding of the association between age at first hormonal contraception and depression. Acta Psychiatr Scand. 2025;151:529-536. https://doi.org/10.1111/acps.13774

11. Hall KS, White KO, Rickert VI, Reame N, Westhoff C. Influence of depressed mood and psychological stress symptoms on perceived oral contraceptive side effects and discontinuation in young minority women. Contraception. 2012;86:518-525. https://doi.org/10.1016/j.contraception.2012.04.010

12. Zethraeus N, Dreber A, Ranehill E, et al. A first-choice combined oral contraceptive influences general well-being in healthy women: a double-blind, randomized, placebo-controlled trial. Fertil Steril. 2017;107(5):1238-1245. https://www.fertstert.org/article/S0015-0282(17)30247-9/fulltext

13. Bengtsdotter H, Lundin C, Gemzell Danielsson K, et al. Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use. Eur J Contracept Reprod Health Care. 2018;23:45-51. https://doi.org/10.1080/13625187.2017.1422239

14. Larsen SV, Mikkelsen AP, Lidegaard Ø, Frokjaer VG. Depression associated with hormonal contraceptive use as a risk indicator for postpartum depression. JAMA Psychiatry. 2023;80:682-689. https://doi.org/10.1001/jamapsychiatry.2023.0807

15. American College of Obstetricians and Gynecologists. Patient-Centered Contraceptive Counseling. ACOG Committee Statement. 2022. https://www.acog.org/clinical/clinical-guidance/committee-statement/articles/2022/02/patient-centered-contraceptive-counseling

Disclaimer

This article is for informational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. ScienceWorks Behavioral Healthcare does not prescribe or manage contraception. Nothing here is a recommendation to start, stop, continue, or switch any contraceptive method — those decisions belong with your prescribing clinician, and stopping a method without a plan carries a risk of unintended pregnancy. Screening tools are not diagnostic instruments. If you are experiencing depression or anxiety symptoms, please speak with a licensed clinician; if you are having thoughts of harming yourself, seek urgent help right away.